9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like Amniox Medical Obtains Federal Supply Schedule Contract For NEOX And CLARIX Product Lines April 16, 2017 Little Exonics Adds Merck's Larger-Than-Life R&D Chief to Its Board of Directors January 29, 2018 Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost June 20, 2017
Amniox Medical Obtains Federal Supply Schedule Contract For NEOX And CLARIX Product Lines April 16, 2017
